$HZNP Recent Headlines Thursday’s biggest gain
Post# of 72741
Posted On: 03/20/2014 5:34:48 PM
$HZNP Recent Headlines
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com
Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog 4:09 p.m. Today - Zacks.com
Horizon Pharma Has Significant Growth Potential 10:28 a.m. Today - Seeking Alpha
Horizon Pharma's CEO Discusses Acquisition of Vidara Therapeutics (Transcript) 4:14 p.m. March 19, 2014 - Seeking Alpha
Why Horizon Pharma (HZPN) Is Up Today 4:00 p.m. March 19, 2014 - TheStreet.com
Horizon Inks Reverse Merger With Vidara 10:30 a.m. March 19, 2014 - FOXBusiness
Horizon Pharma (HZNP) Hits New Lifetime High Today 9:45 a.m. March 19, 2014 - TheStreet.com
Horizon Pharma To Buy Vidara, Join Exodus To Ireland 9:45 a.m. March 19, 2014 - Investors Business Daily
Horizon Pharma to Acquire Vidara in $660 Million Deal 7:49 a.m. March 19, 2014 - The Wall Street Journal Interactive Edition
Horizon and Vidara to marry in a reverse merger 7:14 a.m. March 19, 2014 - Seeking Alpha
UPDATE: Horizon Pharma Announces the Purchase of Vidara Therapeutics for $660M in Stock, Cash 6:13 a.m. March 19, 2014 - benzinga.com
Horizon Pharma (HZNP) Jumps: Stock Rises 5.6% - Tale of the Tape 9:21 a.m. March 18, 2014 - Zacks.com
Horizon Pharma Banks On Two-For-One Arthritis Drugs 1:05 p.m. March 14, 2014 - Investors Business Daily
'Mad Money' Lightning Round: I Want to Buy Time Warner 6:00 a.m. March 14, 2014 - TheStreet.com
Cramer's Lightning Round - I Don't Know What Annaly Is Up To (3/13/14) 5:23 a.m. March 14, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Us vs. Them 7:58 p.m. March 13, 2014 - TheStreet.com
Horizon Pharma's CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:26 p.m. March 13, 2014 - Seeking Alpha
Horizon Pharma Discusses Q4 2013 Results (Webcast) 7:55 a.m. March 13, 2014 - Seeking Alpha
10-K: HORIZON PHARMA, INC. 7:04 a.m. March 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Horizon Pharma Spike Again On Quarterly Report? 7:02 a.m. March 12, 2014 - Investors Business Daily
New Lifetime High Today: Horizon Pharma (HZNP) 9:45 a.m. March 11, 2014 - TheStreet.com
Horizon Pharma Inc. Acquires Vidara Therapeutics in a Reverse Merger Deal Worth $660M in Cash and Stock 12:30 a.m. Today - ACCESSWIRE
Deerfield Provides up to $250 Million in Acquisition Financing to Horizon Pharma 7:15 a.m. March 19, 2014 - BusinessWire - BZX
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc 7:01 a.m. March 19, 2014 - Marketwire
Market Major Trends - New High: Horizon Pharma, Norfolk Southern, Delphi Automotive, and Solazyme 5:40 a.m. March 14, 2014 - PR Newswire - PRF
Horizon Pharma Reports 2013 Financial Results and Provides Business Update 6:30 a.m. March 13, 2014 - Marketwire
Egalet Appoints Timothy P. Walbert to Board of Directors 8:14 a.m. March 11, 2014 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7:30 a.m. March 6, 2014 - Marketwire
Horizon Pharma to Present at the 26th Annual ROTH Conference 7:30 a.m. March 6, 2014 - Marketwire
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 3:30 p.m. March 5, 2014 - PR Newswire - PRF
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:30 a.m. March 5, 2014 - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:30 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:40 p.m. Feb. 11, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:50 p.m. Feb. 6, 2014 - Marketwire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 16th Annual BIO CEO and Investor Conference 7:30 a.m. Feb. 4, 2014 - Marketwire
Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:05 p.m. Jan. 9, 2014 - Marketwire
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 7, 2014 - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:29 a.m. Jan. 2, 2014 - BusinessWire
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com
Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog 4:09 p.m. Today - Zacks.com
Horizon Pharma Has Significant Growth Potential 10:28 a.m. Today - Seeking Alpha
Horizon Pharma's CEO Discusses Acquisition of Vidara Therapeutics (Transcript) 4:14 p.m. March 19, 2014 - Seeking Alpha
Why Horizon Pharma (HZPN) Is Up Today 4:00 p.m. March 19, 2014 - TheStreet.com
Horizon Inks Reverse Merger With Vidara 10:30 a.m. March 19, 2014 - FOXBusiness
Horizon Pharma (HZNP) Hits New Lifetime High Today 9:45 a.m. March 19, 2014 - TheStreet.com
Horizon Pharma To Buy Vidara, Join Exodus To Ireland 9:45 a.m. March 19, 2014 - Investors Business Daily
Horizon Pharma to Acquire Vidara in $660 Million Deal 7:49 a.m. March 19, 2014 - The Wall Street Journal Interactive Edition
Horizon and Vidara to marry in a reverse merger 7:14 a.m. March 19, 2014 - Seeking Alpha
UPDATE: Horizon Pharma Announces the Purchase of Vidara Therapeutics for $660M in Stock, Cash 6:13 a.m. March 19, 2014 - benzinga.com
Horizon Pharma (HZNP) Jumps: Stock Rises 5.6% - Tale of the Tape 9:21 a.m. March 18, 2014 - Zacks.com
Horizon Pharma Banks On Two-For-One Arthritis Drugs 1:05 p.m. March 14, 2014 - Investors Business Daily
'Mad Money' Lightning Round: I Want to Buy Time Warner 6:00 a.m. March 14, 2014 - TheStreet.com
Cramer's Lightning Round - I Don't Know What Annaly Is Up To (3/13/14) 5:23 a.m. March 14, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Us vs. Them 7:58 p.m. March 13, 2014 - TheStreet.com
Horizon Pharma's CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:26 p.m. March 13, 2014 - Seeking Alpha
Horizon Pharma Discusses Q4 2013 Results (Webcast) 7:55 a.m. March 13, 2014 - Seeking Alpha
10-K: HORIZON PHARMA, INC. 7:04 a.m. March 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Horizon Pharma Spike Again On Quarterly Report? 7:02 a.m. March 12, 2014 - Investors Business Daily
New Lifetime High Today: Horizon Pharma (HZNP) 9:45 a.m. March 11, 2014 - TheStreet.com
Horizon Pharma Inc. Acquires Vidara Therapeutics in a Reverse Merger Deal Worth $660M in Cash and Stock 12:30 a.m. Today - ACCESSWIRE
Deerfield Provides up to $250 Million in Acquisition Financing to Horizon Pharma 7:15 a.m. March 19, 2014 - BusinessWire - BZX
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc 7:01 a.m. March 19, 2014 - Marketwire
Market Major Trends - New High: Horizon Pharma, Norfolk Southern, Delphi Automotive, and Solazyme 5:40 a.m. March 14, 2014 - PR Newswire - PRF
Horizon Pharma Reports 2013 Financial Results and Provides Business Update 6:30 a.m. March 13, 2014 - Marketwire
Egalet Appoints Timothy P. Walbert to Board of Directors 8:14 a.m. March 11, 2014 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7:30 a.m. March 6, 2014 - Marketwire
Horizon Pharma to Present at the 26th Annual ROTH Conference 7:30 a.m. March 6, 2014 - Marketwire
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 3:30 p.m. March 5, 2014 - PR Newswire - PRF
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:30 a.m. March 5, 2014 - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:30 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:40 p.m. Feb. 11, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:50 p.m. Feb. 6, 2014 - Marketwire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 16th Annual BIO CEO and Investor Conference 7:30 a.m. Feb. 4, 2014 - Marketwire
Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:05 p.m. Jan. 9, 2014 - Marketwire
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 7, 2014 - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:29 a.m. Jan. 2, 2014 - BusinessWire
(0)
(0)